Supriya Lifescience gets GMP certification from ANVISA Brazil
ANVISA certification will help Supriya Lifescience to strategically grow its footprint in the Brazilian pharmaceutical sector and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Brazil
Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply
According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially
Biocon Pharma joins hands with Libbs Farmaceutica to launch generic medicines in Brazil
Biocon Pharma will be responsible for drug development and manufacturing of the medicines, while Libbs will import, distribute and…
Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN
It has signed an agreement for the delivery of COVAXIN during Q2 and Q3 2021
Beyond highly developed pharma markets! Wild card access to less explored, high entry barrier…
Sameer Kolhe, President, Maypharm Life Sciences highlights that COVID-19 brings some ‘challenging’ markets within reach for the…
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate
The Johnson & Johnson vaccine candidate is the fourth to be approved for human trials in Brazil
Number of US COVID-19 clinical trials surpasses China: GlobalData
Clinical trials in India also growing at a higher rate, and the country is now in fourth place for COVID-19 trials
Brazil approves human trials for third COVID-19 vaccine in collaboration with Pfizer, BioNTech
The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful
Brazil to test Sinovac’s potential vaccine against COVID-19 in six states
The agreement with Sinovac includes not only trials but also the transference of technology to produce the coronavirus vaccine…
Brazil signs agreement to produce AstraZeneca’s COVID-19 vaccine candidate
The country will initially produce some 30 million doses of the vaccine